Contract Deobligations Alert — August 12, 2026

QTC Medical Services (Leidos) secured a $113.9 million firm-fixed-price delivery order from the VA, with 92% already outlaid, indicating near-complete revenue realization and low performance risk. The contract is tied to the Veterans Benefits Improvement Act, ensuring stable, mandated funding.

Hoffmann-La Roche's $183.8 million obligated contract (base+options $259.8M) with BARDA runs through 2028, but the cost-no-fee structure limits margin contribution, making it a stable but low-upside revenue stream.

Jacobs Engineering won a firm-fixed-price BPA call for construction management on 11 border patrol stations, with a total potential value of $162.3 million through 2031. The fixed-price structure carries high execution risk, but the 5-year period provides revenue visibility.

Despite a $212.5 million obligation, only $14.6 million (7%) has been outlaid over a 16-year period, suggesting potential underperformance or funding delays. The contract's end date in September 2024 adds uncertainty about renewal.

Jacobs' $105.6 million contract for 11 design-build border patrol stations is firm-fixed-price, meaning cost overruns could erode margins. The complexity of construction management across four states increases execution risk.

With only $14.6 million outlaid against a $212.5 million obligation, there is a significant gap that may indicate delayed funding or underperformance. The contract's end date in September 2024 adds re-competition risk.

HHS contracts (CMS and BARDA) account for 64% of total obligations, making the digest heavily reliant on healthcare-related funding. Any policy shift in Medicare administration or biodefense R&D could impact a significant portion of the total value.

Leidos' successful execution on the Midwest VA disability exam contract (92% outlaid) positions it well for future VA solicitations in other regions, given the mandated demand under the Veterans Benefits Improvement Act.

The $105.6 million CBP contract for border patrol stations aligns with current immigration enforcement priorities, and the $162.3 million total potential value suggests room for expansion if options are exercised.

Roche's 12-year BARDA contract for biodefense R&D may lead to follow-on contracts or modifications if the program succeeds, despite the cost-no-fee structure limiting current margins.

HHS contracts (CMS and BARDA) account for $396.4 million (64%) of the total digest, highlighting the scale of healthcare-related federal spending. Palmetto GBA's Medicare administrative services and Roche's biodefense R&D are key examples.

DHS/CBP's $105.6 million award to Jacobs for border patrol station construction signals sustained investment in border security infrastructure, despite political uncertainty.

Leidos' VA contract is tied to the Veterans Benefits Improvement Act, ensuring consistent funding for disability exams. The 92% outlay rate demonstrates reliable revenue realization.

{"entity" => "Leidos Holdings", "reason" => "Strong execution on VA disability exam contract (92% outlaid) and potential for regional expansion.", "trigger" => "VA solicitation for disability exams in other regions"}

{"entity" => "Jacobs Engineering Group", "reason" => "High execution risk on firm-fixed-price border infrastructure contract; option exercise could increase value to $162.3M.", "trigger" => "Option exercise on CBP BPA call or project milestones"}

{"entity" => "Palmetto GBA", "reason" => "Low outlay rate (7%) on $212.5M CMS contract; renewal or re-competition post-2024 is critical.", "trigger" => "CMS contract renewal or re-compete announcement"}

{"entity" => "Roche", "reason" => "Long-term BARDA R&D contract could lead to follow-on awards if program succeeds.", "trigger" => "BARDA option exercise or new R&D contract announcements"}